Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Livanova Plc OR Sh
(NQ:
LIVN
)
53.85
+0.64 (+1.20%)
Streaming Delayed Price
Updated: 10:36 AM EDT, Oct 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Livanova Plc OR Sh
< Previous
1
2
3
4
5
Next >
LivaNova Receives FDA Approval for Clinical Study to Evaluate the aura6000 System to Treat Obstructive Sleep Apnea
June 15, 2021
From
LivaNova PLC
Via
Business Wire
LivaNova Completes Initial Closing of Heart Valve Business to Gyrus Capital
June 01, 2021
From
LivaNova PLC
Via
Business Wire
LivaNova to Present at the UBS Global Healthcare Virtual Conference
May 13, 2021
From
LivaNova PLC
Via
Business Wire
Recap: LivaNova Q1 Earnings
April 28, 2021
Shares of LivaNova (NASDAQ:LIVN) were unchanged after the company reported Q1 results. Quarterly Results Earnings per share rose 6.06% year over year to $0.35, which beat...
Via
Benzinga
LivaNova PLC (LIVN) Q1 2021 Earnings Call Transcript
April 28, 2021
LIVN earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
LivaNova Reports First Quarter 2021 Results
April 28, 2021
From
LivaNova PLC
Via
Business Wire
LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression
April 26, 2021
From
LivaNova PLC
Via
Business Wire
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
April 20, 2021
From
LivaNova PLC
Via
Business Wire
LivaNova Achieves Clinical Milestone in Heart Failure Program
April 19, 2021
From
LivaNova PLC
Via
Business Wire
10 Biggest Price Target Changes For Tuesday
April 13, 2021
Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.